Breakthrough drug category demands more communication
Carroll, J.
Managed Care 22(8): 17-18
2013
ISSN/ISBN: 1062-3388 PMID: 24024248 Document Number: 667244
Document emailed within 1 workday
Related Documents
Hewitt, F.S. 1981: Communication skills: blockage and breakthrough Nursing Times 77(43): Suppl. 37-40Peckman, H. 2010: The U.S. Food and Drug Adminstration (FDA) has assigned pregnancy category D to valproate North Carolina Medical Journal 71(4): 396-398
Nordstedt, C.; Näslund, J.; Tjernberg, L.O.; Terenius, L. 1995: A breakthrough for research on Alzheimer disease. a model for drug testing Lakartidningen 92(18): 1899-1900
Martínez Riera, J.é R.ón. 2012: Challenges and responses to demands of family and community nursing demands Revista de Enfermeria 35(4): 76-77
Van Vaerenbergh, K.; Harrer, T.; Schmit, J-C.; Carbonez, A.; Fontaine, E.; Kurowski, M.; Grünke, M.; Löw, P.; Rascu, A.; Schmidt, B.; Schmitt, M.; Thoelen, I.; Walter, H.; Van Laethem, K.; Van Ranst, M.; Desmyter, J.; De Clercq, E.; Vandamme, A-M. 2002: Initiation of HAART in drug-naive HIV type 1 patients prevents viral breakthrough for a median period of 35.5 months in 60% of the patients Aids Research and Human Retroviruses 18(6): 419-426
Yamada, Y.; Nakahara, M.; Kohno, M.; Otsuka, M.; Takaiti, O. 1989: Metabolic fate of the new anti-ulcer drug enprostil in animals. 4th communication: effect on hepatic drug metabolizing enzyme system in rats Arzneimittel-Forschung 39(3): 356-360
Potocka, A.; Waszkowska, M.łg. 2013: Application of job demands-resources model in research on relationships between job satisfaction, job resources, individual resources and job demands Medycyna Pracy 64(2): 217-225
Light, J.; McNaughton, D.; Beukelman, D.; Fager, S.Koch.; Fried-Oken, M.; Jakobs, T.; Jakobs, E. 2019: Challenges and opportunities in augmentative and alternative communication: Research and technology development to enhance communication and participation for individuals with complex communication needs Augmentative and Alternative Communication 35(1): 1-12
Light, J.; McNaughton, D.; Beukelman, D.; Fager, S.Koch.; Fried-Oken, M.; Jakobs, T.; Jakobs, E. 2019: Challenges and opportunities in augmentative and alternative communication: Research and technology development to enhance communication and participation for individuals with complex communication needs Augmentative and Alternative Communication 35(1): 1-12
White, A.J.; Stevenson, V.M. 1975: The effects to total communication, manual communication, oral communication and reading on the learning of factual information in residential school deaf children American Annals of the Deaf 120(1): 48-57
Trimble, G.X. 1973: Drug names in communication by Ishibashi et al. (pyritinol) Archives of Dermatology 108(3): 423
Samková, M.; Solich, J. 1977: Studies on the production and demands of infusions and sterile drug preparations in the Czech Socialist Republic. I. Apparatus for production of sterile drug preparations in the Czech Socialist Republic Ceskoslovenska Farmacie 26(9): 406-412
Marinov, B.; Petkova, C.; Kolarov, G.; Georgiev, S.; Iunakova, M. 2003: Some opportunities for the application of the drug mycosyst (preliminary communication) Akusherstvo i Ginekologiia 42 Suppl. 1: 15-17
Wolthuis, K.; Bol, G.W.; Minnaert, A.; Janssen, M.J. 2019: Communication development from an intersubjective perspective: Exploring the use of a layered communication model to describe communication development in students with congenital deafblindness Journal of Communication Disorders 80: 35-51
Wolthuis, K.; Bol, G.W.; Minnaert, A.; Janssen, M.J. 2019: Communication development from an intersubjective perspective: Exploring the use of a layered communication model to describe communication development in students with congenital deafblindness Journal of Communication Disorders 80: 35-51
Budden, R.; Kühl, U.G.; Buschmann, G. 1978: Studies on the pharmacodynamic activity of several drug solvents. 1st communication: Diethyleneglycol monoethylether, N,N-diethylacetamide, dimethylsufoxide Arzneimittel-Forschung 28(9): 1571-1579
Imade, G.E.; Sagay, A.S.; Chaplin, B.; Chebu, P.; Musa, J.; Okpokwu, J.; Hamel, D.J.; Pam, I.C.; Agbaji, O.; Samuels, J.; Meloni, S.; Sankale, J-Louis.; Okonkwo, P.; Kanki, P. 2014: Short communication: Transmitted HIV drug resistance in antiretroviral-naive pregnant women in north central Nigeria Aids Research and Human Retroviruses 30(2): 127-133
Yanagihara, Y.; Abe, T.; Kuroda, T.; Shida, T. 1988: Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 5th communication: effects on immunological reactions in mice and humans Arzneimittel-Forschung 38(1): 88-92
Amran, S.; Ahmed, M.; Shaheen, S.M.; Morshed, S.Niaz.; Khandakar, J.; Rahman, M.; Rahman, M.; Hossain, A. 2007: Short communication: a study on the packaging information of essential drug products used at Union and Thana health complex level in Bangladesh Pakistan Journal of Pharmaceutical Sciences 20(4): 327-332
Bucy, P.C. 1978: Another breakthrough Surgical Neurology 10(1): 44